Expectations and concerns regarding emerging new disease-modifying drugs for multiple sclerosis: What can we expect in the future?

Jun Ichi Kira

研究成果: Contribution to journal › Editorial › 査読

本文言語	英語
ページ（範囲）	273-274
ページ数	2
ジャーナル	Clinical and Experimental Neuroimmunology
巻	5
号	3
DOI	https://doi.org/10.1111/cen3.12142
出版ステータス	出版済み - 10 1 2014

All Science Journal Classification (ASJC) codes

@article{1b003446ee82448ea2e800ddf52dfbdd,

title = "Expectations and concerns regarding emerging new disease-modifying drugs for multiple sclerosis: What can we expect in the future?",

author = "Kira, {Jun Ichi}",

year = "2014",

month = oct,

day = "1",

doi = "10.1111/cen3.12142",

language = "English",

volume = "5",

pages = "273--274",

journal = "Clinical and Experimental Neuroimmunology",

issn = "1759-1961",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Expectations and concerns regarding emerging new disease-modifying drugs for multiple sclerosis

T2 - What can we expect in the future?

AU - Kira, Jun Ichi

PY - 2014/10/1

Y1 - 2014/10/1

UR - http://www.scopus.com/inward/record.url?scp=84908151431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908151431&partnerID=8YFLogxK

U2 - 10.1111/cen3.12142

DO - 10.1111/cen3.12142

M3 - Editorial

AN - SCOPUS:84908151431

VL - 5

SP - 273

EP - 274

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 3

ER -